miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 10731-10736

  Ma, Ying ^a   She, Xing guo ^a   Ming, Ying zi ^a   Wan, Qi quan ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Invasion; Migration; miR 24; Proliferation; SOX7

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MIRN24 MICRORNA, HUMAN; SOX7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

APOPTOSIS; CELL MOTION; CELL PROLIFERATION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; LIVER NEOPLASMS; LUCIFERASES; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOXF TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 84923777516     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2018-6     Document Type: Article

References (24)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Asia-Pacific Working Party on Prevention of Hepatocellular C. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements. J Gastroenterol Hepatol. 2010;25:657–63.
3. Li Z, Zhang C, Lou C, Yan F, Mao Y, Hong X, et al. Comparison of percutaneous cryosurgery and surgical resection for the treatment of small hepatocellular carcinoma. Oncol Lett. 2013;6:239–45.
4. Shah MY, Calin GA. Micrornas as therapeutic targets in human cancers. Wiley interdisciplinary reviews RNA 2014.
5. Mulrane L, Klinger R, McGee SF, Gallagher WM, O'Connor DP. MicroRNAs: a new class of breast cancer biomarkers. Expert Rev Mol Diagn. 2014;14:347–63.
6. Ke Y, Zhao W, Xiong J, Cao R. Downregulation of mir-16 promotes growth and motility by targeting hdgf in non-small cell lung cancer cells. FEBS Lett. 2013;587:3153–7.
7. Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, et al. Mir-122 targets pyruvate kinase m2 and affects metabolism of hepatocellular carcinoma. PLoS One. 2014;9:e86872.
8. Duan X, Hu J, Wang Y, Gao J, Peng D, Xia L. Microrna-145: a promising biomarker for hepatocellular carcinoma (hcc). Gene. 2014;541:67–8.
9. Xia J, Guo X, Yan J, Deng K. The role of mir-148a in gastric cancer. Journal of cancer research and clinical oncology 2014.
10. Franchina T, Amodeo V, Bronte G, Savio G, Ricciardi GR, Picciotto M, et al. Circulating mir-22, mir-24 and mir-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer. J Cell Physiol. 2014;229:97–9.
11. Giglio S, Cirombella R, Amodeo R, Portaro L, Lavra L, Vecchione A. MicroRNA mir-24 promotes cell proliferation by targeting the CDKs inhibitors p27kip1 and p16ink4a. J Cell Physiol. 2013;228:2015–23.
12. Salvi A, Abeni E, Portolani N, Barlati S, De Petro G. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of mir-24 and mir-27a in cirrhotic/non-cirrhotic hcc. Int J Oncol. 2013;42:391–402.
13. Lo TF, Tsai WC, Chen ST. Microrna-21-3p, a berberine-induced miRNA, directly down-regulates human methionine adenosyltransferases 2a and 2b and inhibits hepatoma cell growth. PLoS One. 2013;8:e75628.
14. Wang N, Zhu M, Tsao SW, Man K, Zhang Z, Feng Y. Mir-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma. Mol Cancer. 2013;12:119.
15. Yang J, Zhang JY, Chen J, Xu Y, Song NH, Yin CJ. Prognostic role of microrna-221 in various human malignant neoplasms: a meta-analysis of 20 related studies. PLoS One. 2014;9:e87606.
16. Fu Y, Wei X, Tang C, Li J, Liu R, Shen A, et al. Circulating microrna-101 as a potential biomarker for hepatitis b virus-related hepatocellular carcinoma. Oncol Lett. 2013;6:1811–5.
17. Du WW, Fang L, Li M, Yang X, Liang Y, Peng C, et al. MicroRNA mir-24 enhances tumor invasion and metastasis by targeting ptpn9 and ptprf to promote egf signaling. J Cell Sci. 2013;126:1440–53.
18. Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K, et al. Mir-24-3p and mir-27a-3p promote cell proliferation in glioma cells via cooperative regulation of mxi1. Int J Oncol. 2013;42:757–66.
19. Stovall DB, Cao P, Sui G. Sox7: From a developmental regulator to an emerging tumor suppressor. Histology and histopathology 2013.
20. Stovall DB, Wan M, Miller LD, Cao P, Maglic D, Zhang Q, et al. The regulation of sox7 and its tumor suppressive role in breast cancer. Am J Pathol. 2013;183:1645–53.
21. Hayano T, Garg M, Yin D, Sudo M, Kawamata N, Shi S, et al. Sox7 is down-regulated in lung cancer. J Exp Clin Cancer Res CR. 2013;32:17.
22. Li B, Ge Z, Song S, Zhang S, Yan H, Huang B, et al. Decreased expression of sox7 is correlated with poor prognosis in lung adenocarcinoma patients. Pathol Oncol Res POR. 2012;18:1039–45.
23. Zhou X, Huang SY, Feng JX, Gao YY, Zhao L, Lu J, et al. Sox7 is involved in aspirin-mediated growth inhibition of human colorectal cancer cells. World J Gastroenterol WJG. 2011;17:4922–7.
24. Wu GG, Li WH, He WG, Jiang N, Zhang GX, Chen W, et al. Mir-184 post-transcriptionally regulates sox7 expression and promotes cell proliferation in human hepatocellular carcinoma. PLoS One. 2014;9:e88796.